The estimated Net Worth of Inc. Medytox is at least 85 百万$ dollars as of 16 October 2023. Inc Medytox owns over 1,690,663 units of Evolus Inc stock worth over 51,632,848$ and over the last 3 years Inc sold EOLS stock worth over 33,399,789$.
Inc has made over 15 trades of the Evolus Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Inc sold 1,690,663 units of EOLS stock worth 12,679,973$ on 16 October 2023.
The largest trade Inc's ever made was selling 2,187,511 units of Evolus Inc stock on 7 February 2023 worth over 18,593,844$. On average, Inc trades about 321,358 units every 53 days since 2021. As of 16 October 2023 Inc still owns at least 3,381,326 units of Evolus Inc stock.
You can see the complete history of Inc Medytox stock trades at the bottom of the page.
Inc's mailing address filed with the SEC is 78, GANGNI 1-GIL, OCHANG-EUP,, CHEONGWON-GU, CHEOGIU-SI, M5, 28126.
Over the last 7 years, insiders at Evolus Inc have traded over 244,915,132$ worth of Evolus Inc stock and bought 3,308,677 units worth 53,545,237$ . The most active insiders traders include Biopharma, Inc. Aeon、Inc. Medytox、1 Llc Alphaeon. On average, Evolus Inc executives and independent directors trade stock every 25 days with the average trade being worth of 3,606,270$. The most recent stock trade was executed by Sandra Beaver on 6 September 2024, trading 3,276 units of EOLS stock currently worth 49,074$.
evolus, inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the united states. it offers jeuveau, a proprietary 900 kilodalton purified botulinum toxin type a formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. the company was founded in 2012 and is headquartered in newport beach, california.
Evolus Inc executives and other stock owners filed with the SEC include: